Select a Region
North America

Browsing Archive: Scientific InsightsScientific Insights | EVERSANA

EVERSANA
Posted on 6 月 12, 20256/12/25

Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema

EVERSANA
Posted on 5 月 8, 20255/8/25

Continuous glucose monitoring for self-management of diabetes in people living with type 2 diabetes mellitus on basal insulin therapy: A microsimulation model and cost-effectiveness analysis from a US perspective with relevance to Medicaid

EVERSANA
Posted on 5 月 8, 20255/8/25

The economic impact associated with stent retriever selection for the treatment of acute ischemic stroke: a cost–effectiveness analysis of MASTRO I data from a Chinese healthcare system perspective

EVERSANA
Posted on 5 月 8, 20255/8/25

A U.S. payer budget impact analysis of Flurpiridaz-PET-MPI compared to SPECT-MPI in the diagnosis of coronary artery disease

EVERSANA
Posted on 5 月 8, 20255/8/25

Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancer

EVERSANA
Posted on 5 月 8, 20255/8/25

Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2− advanced/metastatic breast cancer: updated systematic review

EVERSANA
Posted on 4 月 29, 20254/29/25

Efficacy and safety of crizotinib in the treatment of advanced non-small cell lung cancer with ROS1 gene fusion: a systematic literature review and meta-analysis of real-world evidence

EVERSANA
Posted on 4 月 29, 20254/29/25

The economic impact associated with stent retriever selection for the treatment of acute ischemic stroke: a cost–effectiveness analysis of MASTRO I data from a Chinese healthcare system perspective

EVERSANA
Posted on 4 月 29, 20254/29/25

A U.S. payer budget impact analysis of Flurpiridaz-PET-MPI compared to SPECT-MPI in the diagnosis of coronary artery disease

EVERSANA
Posted on 4 月 29, 20254/29/25

Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancer

Scientific Insights